Truist raised the firm’s price target on National Health Investors (NHI) to $77 from $76 and keeps a Hold rating on the shares as part of a broader research note updating the firm’s estimates on Healthcare REITs. Truist is expecting the National Healthcare Corporation (NHC) lease to ultimately be renewed at a 10%-15% higher rental rate, even though the outcome of renewal remains uncertain, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NHI:
- National Health Investors Updates Investment Pipeline Strategy
- National Health Investors Holds 2025 Annual Meeting
- National Health Investors issues statement in response to ISS recommendation
- Land & Buildings says ISS recommends NHI stockholders vote for director nominees
- Proxy firm recommends National Health investors vote for L&B nominees